Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors
- 19 April 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (11), 2027-2030
- https://doi.org/10.1021/jm0256169
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacological inhibitors of cyclin-dependent kinasesTrends in Pharmacological Sciences, 2002
- Cyclin-Dependent Kinase Inhibitors: Useful Targets in Cell Cycle RegulationJournal of Medicinal Chemistry, 2000
- Four-dimensional control of the cell cycleNature Cell Biology, 1999
- Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G 1 arrest after γ-irradiationProceedings of the National Academy of Sciences, 1999
- Purification, Characterization, and Kinetic Mechanism of Cyclin D1·CDK4, a Major Target for Cell Cycle RegulationJournal of Biological Chemistry, 1998
- CYCLIN-DEPENDENT KINASES: Engines, Clocks, and MicroprocessorsAnnual Review of Cell and Developmental Biology, 1997
- Cell Cycle Checkpoints: Preventing an Identity CrisisScience, 1996
- Cell Cycle Control and CancerScience, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Synthesis of the aromatic and monosaccharide moieties of staurosporineThe Journal of Organic Chemistry, 1987